Mechanistic insights into CLNS1A-mediated chemoresistance and tumor progression in non-small cell lung cancer - Wei, Tong-You Wade; Hsia, Jiun-Yi; Yang, Tsung-Ying; Huang, Yu-Xu; Wang, Guo-Zhi; Liu, Yi-Chung; Wang, Yi-Wun; He, Fangzhou; Chen, Jo-Mei Maureen; Zhao, Guo-Jun; Lyu, Ping-Chiang; Su, Li-Jen; et al. (Cancer letters, 2025)
Keywords: Animals; Antineoplastic Agents - pharmacology; Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - genetics; Carcinoma, Non-Small-Cell Lung - metabolism; Carcinoma, Non-Small-Cell Lung - pathology; Cell Line, Tumor; Cell Movement - drug effects; Chemoresistance; Chloride channel; Chloride Channels - genetics; Chloride Channels - metabolism; Cisplatin - pharmacology; Disease Progression; DNA damage response; DNA Helicases - genetics; DNA Helicases - metabolism; Drug Resistance, Neoplasm - genetics; Gene Expression Regulation, Neoplastic; Humans; Lung cancer; Lung Neoplasms - drug therapy; Lung Neoplasms - genetics; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Metastasis; Mice; Mice, Nude; Protein-Arginine N-Methyltransferases - genetics; Protein-Arginine N-Methyltransferases - metabolism; Signal Transduction; Xenograft Model Antitumor Assays; Chloride channel; Metastasis; DNA damage response; Lung cancer; Chemoresistance